Milan, Italy

Alberto Tajano

This inventor holds 1 USPTO granted patent. Top assignee: Recordati S.a.. Active years: 1981.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alberto Tajano. Retrieved from https://idiyas.com/inventor/alberto-tajano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1981

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alberto Tajano: Innovator in Imidazole Derivatives

Introduction

Alberto Tajano is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly through his work on imidazole derivatives. His innovative approach has led to the development of compounds that hold potential therapeutic applications.

Latest Patents

Tajano holds a patent for imidazole derivatives, specifically those of the formula I and pharmaceutically acceptable acid addition salts thereof. The patent details various substituents, including 1- or 2-naphthyl, which may be optionally substituted with halogens such as Cl, Br, or I. This patent represents a significant advancement in the chemistry of imidazole compounds.

Career Highlights

Alberto Tajano is associated with Recordati S.A., a company known for its focus on pharmaceuticals. His work has contributed to the company's reputation for innovation in drug development. With a total of 1 patent, Tajano's contributions are recognized within the industry.

Collaborations

Throughout his career, Tajano has collaborated with esteemed colleagues, including Dante Nardi and Maria J. Magistretti. These partnerships have fostered a collaborative environment that enhances research and development efforts.

Conclusion

Alberto Tajano's work in the field of imidazole derivatives showcases his innovative spirit and dedication to pharmaceutical advancements. His contributions continue to influence the industry and pave the way for future discoveries.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…